Table 1.
Comparison of clinicopathological features of patients with TGM1 low and high gastric cancer
| Factors | Total | TGM1 expression |
P value | |
|---|---|---|---|---|
| Low (%) | High (%) | |||
| Gender | 0.423 | |||
| Male | 79 | 38 (48.1) | 41 (51.9) | |
| Female | 17 | 10 (58.8) | 7 (41.2) | |
| Age (years) | 0.679 | |||
| <60 | 40 | 19 (47.5) | 21 (52.5) | |
| ≥60 | 56 | 29 (51.8) | 27 (48.2) | |
| Location | 0.214 | |||
| Upper and middle stomach | 40 | 23 (57.5) | 17 (42.5) | |
| Lower stomach | 56 | 25 (44.6) | 31 (55.4) | |
| Tumor size (cm) | 0.138 | |||
| <6 | 61 | 34 (55.7) | 27 (44.3) | |
| ≥6 | 35 | 14 (40.0) | 21 (60.0) | |
| Differentiation | 0.088 | |||
| High/moderate | 34 | 21 (61.8) | 13 (38.2) | |
| Low/undifferentiated | 62 | 27 (43.5) | 35 (56.5) | |
| Gastric wall invasion | 0.083 | |||
| T1–T2 | 32 | 12 (37.5) | 20 (62.5) | |
| T3–T4 | 64 | 36 (56.3) | 28 (43.7) | |
| Lymph node metastasis | 0.021* | |||
| Yes | 59 | 24 (40.7) | 35 (59.3) | |
| No | 37 | 24 (64.9) | 13 (35.1) | |
| TNM stage | 0.028* | |||
| I–II | 30 | 20 (66.7) | 10 (33.3) | |
| III–IV | 66 | 28 (42.4) | 38 (57.6) | |
*
P value < 0.05 was considered statistically significance.